Wild times in the world of remote cardiac monitoring. Following Philips’s $2.8B acquisition of BioTelemetry in December, in the past few days Hillrom announced a $375M deal for Bardy Diagnostics, and Boston Scientific shared plans to snap up Preventice Solutions for $925M. All three acquired companies offer connected patch devices to monitor and diagnose heart rhythm disorders. What should we make of this rapid $4B+ in acquisitions of a trio of competitors? For one, there aren’t many startups remaining in the remote ECG market. More broadly, it’s clear that remote patient monitoring is going to be the standard of care for patients with heart rhythms disorders.
Black Americans Are Getting Vaccinated At Lower Rates Than White Americans
Communities at highest risk face systemic obstacles in access and communication Kaiser Health News | (Tweet)
Humana Launches “Author” To Compete With Insurance Startups
Startups like Clover, Oscar, and Devoted make insurance incumbents “better” Business Insider | (Tweet)
Tripathi Tapped As Biden's National Coordinator For Health IT
Interoperability and privacy expert takes the reins Fierce Healthcare | (Tweet)